Concepedia
Statistics
Publications
8
Citations
257
H-Index
Active since
2019
Affiliations
Université de Bordeaux(Current)
Inserm
Bordeaux Population Health
Centre Hospitalier Universitaire de Bordeaux
Centre National de la Recherche Scientifique
Samuel Amintas is an author at Université de Bordeaux specializing in oncology, medicine, and crispr-cas systems.
Publications per year
2019–2025
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
Julian Boutin, Juliette Rosier, David Cappellen et al. · Nature Communications · 2021 · 85 citations · Full text
Life Sciences, Genetics, Molecular Genetics +13
Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death
V. Vendrely, Samuel Amintas, Cécile Noël et al. · Cancer Letters · 2019 · 46 citations · Full text
Medicine, Oncology, Radiation Oncology +14
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
Pietro Rosellini, Samuel Amintas, Charline Caumont et al. · European Journal of Cancer · 2022 · 45 citations
Medicine, Molecular Genetics, Oncology +11
Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9
Grégoire Cullot, Julian Boutin, Sabrina Fayet et al. · Nature Communications · 2023 · 32 citations · Full text
Life Sciences, Genetics, Molecular Biology +13
KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence
Samuel Amintas, Benjamı́n Fernández, Alexandre Chauvet et al. · Scientific Reports · 2022 · 16 citations · Full text
Medicine, Oncology, Pathology +17
1–5 of 8